The drug is already approved for KMT2A-rearranged AML, and Syndax is hoping for approval in NPM1-mutated disease by the end of the year.

Approval of Zusduri was based on data from the Phase III ENVISION trial, which showed a 78% complete response at three months ...

The drug pipeline—the process through which a potential new drug gets discovered, tested, approved, and marketed—is a ...

Accelerating the Growth of Globally Active Drug-Discovery Startups from Japan TOKYO, June 13, 2025 /PRNewswire/ -- Mitsubishi Research Institute, Inc.

The End Prescription Drug Ads Now Act would apply to all drugs and biologics across TV, social media, print, digital and ...

Rep Kim Schrier, MD, (D-Wash.), said on X yesterday that some of the newly appointed ACIP replacements are anti-vaccine ...

The FDA has accepted the NDA for zoliflodacin for the treatment of uncomplicated gonorrhea in adults and pediatric patients 12 years and older.

The warning letters deal with a range of violations involving items from personal hygienic products to mismarketed analgesics.

Treatment with the investigational therapeutic rusfertide has proven to be a potential treatment option for patients with ...

The psychedelics community is making a trip to Denver this month for what’s billed as the country’s largest conferences ...

Published in the Journal of Medicinal Chemistry, the study shows that the new molecule—called POM-L-BHDU—can effectively ...

Tebipenem's approval in 2026 under SPA could bring Spero $400M+ in milestones & royalties. Read more on why SPRO is a Buy, ...